Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

gsk.com

Press releases

Get the latest updates from Press releases directly as they happen.

Follow now 487 followers

Latest posts

Last updated 2 days ago

Penmenvy, GSK’s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY

1 day ago

Vaccine helps protect against five common disease-causing serogroups of Neisseria meningitidis (A...

European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents

17 days ago

Vocabria + Rekambys (cabotegravir + rilpivirine) is the first and only complete...

Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP

20 days ago

If approved, depemokimab will be the first ultra-long-acting biologic with 6-month dosing.

Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP

20 days ago

If approved, depemokimab will be the first ultra-long-acting biologic with 6-month dosing

GSK and Oxford establish the GSK-Oxford Cancer Immuno-Prevention Programme to advance novel cancer research

20 days ago

Collaboration unites GSK and Oxford’s complementary expertise in the science of the...

GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency

21 days ago

Over 25 million people in Europe have received GSK’s shingles vaccine since...

European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer

28 days ago

Expanded approval includes MMRp/MSS tumours, which represent approximately 75% of endometrial cancer...

GSK enters agreement to acquire IDRx, Inc.

about 1 month ago

Acquisition adds to GSK’s growing portfolio in gastrointestinal (GI) cancers

GSK’s Shingrix new prefilled syringe presentation accepted for review by US FDA

about 1 month ago

If approved, the new presentation will offer a convenient administration option to...

GSK’s Nucala (mepolizumab) approved in China for treatment of adults with chronic rhinosinusitis with nasal polyps

about 1 month ago

This is the third indication for mepolizumab in China for an IL-5...